MedicarePartD.guide

A non-government resource built from CMS public data

LOTEMAX SM 3.8 mg/g Gel

Also known as Loteprednol Etabonate. Coverage in Hawaii (CMS PDP Region 33).

5 of 8 stand-alone Part D plans in Hawaii cover this drug on tier 3–4.

No plan applies a prior authorization, step therapy or quantity limit.

12 Medicare Advantage plans in HI do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. HI: 12 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
SilverScript Choice (PDP)$14.70/mo premium · $615.00 deductible3Preferred Brand19%19%$52.2114—None
Humana Basic Rx Plan (PDP)$0.40/mo premium · $615.00 deductible4Non-Preferred Drug28%—$50.1245—None
Humana Value Rx Plan (PDP)$51.60/mo premium · $601.00 deductible4Non-Preferred Drug30%—$50.1245—None
Humana Premier Rx Plan (PDP)$90.20/mo premium · $0.00 deductible4Non-Preferred Drug50%50%$50.1245—None
AARP Medicare Rx Preferred from UHC (PDP)$139.20/mo premium · $130.00 deductible4Non-Preferred Drug34%—$52.6025—None

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →